Healthcare Distribution Alliance – Patients Move Us.
Share Print


HDA and NACDS Call on Congress to Protect Patient Safety by Rejecting Drug Importation Proposals

May 8, 2017

In an opinion piece published today in the Capitol Hill newspaper, The Hill, HDA and NACDS called on members of Congress to honor its commitment to protecting patients and the safety of the supply chain by rejecting any proposal that would call for the importation of prescription drugs from foreign markets.

The op-ed was authored by HDA President and CEO John M. Gray and NACDS President and CEO Steven C. Anderson, who stated, “We at the NACDS and HDA are voicing our strong opposition to any amendment to allow for importation. Such a proposal will dismantle the hard work supply chain stakeholders and regulators have undertaken since the passage of the groundbreaking Drug Supply Chain Security Act (DSCSA) nearly four years ago.”

Read the op-ed


The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.


NACDS represents traditional drug stores, supermarkets and mass merchants with pharmacies, and supplier partners. Chains operate 40,000 pharmacies, and NACDS’ member companies include regional chains with at least four stores and national companies. Chains employ more than 3.2 million people, including 178,000 pharmacists. For more information, visit

© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365